Sleep

Home-based postural exercise as an adjunct to duloxetine improves sleep quality, physical quality of life, and trunk mobility in fibromyalgia: a randomized controlled trial.

TL;DR

Adding a home-based postural exercise program to duloxetine therapy may provide short-term additional benefits in sleep quality, physical quality of life, and spinal mobility in individuals with fibromyalgia syndrome.

Key Findings

Home-based postural exercise added to duloxetine produced significantly greater improvements in sleep quality compared to duloxetine alone.

  • Sleep quality was assessed using the Pittsburgh Sleep Quality Index (PSQI)
  • Significant group × time interaction favored the exercise group (F = 11.07, p = 0.002, η² = 0.184)
  • η² = 0.184 indicates a large effect size for this between-group difference
  • Both groups received duloxetine; only the exercise group performed a home-based postural exercise program three times per week for four weeks

The exercise group showed significantly greater improvement in physical quality of life compared to the control group.

  • Physical quality of life was assessed using the physical component of the Short Form-12 (SF-12)
  • Significant group × time interaction favored the exercise group (F = 4.31, p = 0.043, η² = 0.081)
  • No significant group × time interaction was found for the mental component of the SF-12 (p > 0.05)
  • η² = 0.081 indicates a medium effect size for the physical component difference

Trunk range of motion improved significantly more in the exercise group than in the control group across all measured directions.

  • Trunk flexion showed a significant group × time interaction favoring the exercise group (F = 20.85, p < 0.001, η² = 0.299)
  • Trunk extension also showed a significant group × time interaction (F = 8.34, p = 0.006, η² = 0.146)
  • Global trunk ROM showed the largest effect: F = 35.10, p < 0.001, η² = 0.417
  • η² = 0.417 for global trunk ROM represents a very large effect size

Both groups showed significant improvements over time in pain intensity, psychological symptoms, sleep quality, quality of life, and pressure pain threshold, regardless of exercise assignment.

  • Significant within-group improvements over time were observed in pain intensity, psychological symptoms, sleep quality, quality of life, and pressure pain threshold (PPT) in both groups (p < 0.05)
  • These improvements are attributable to duloxetine therapy received by both groups
  • The intervention duration was four weeks with no follow-up assessment conducted

No significant between-group differences were found for pain intensity, anxiety, depression, mental quality of life, or pressure pain threshold.

  • No significant group × time interactions were observed for pain intensity, anxiety, depression, mental quality of life, or PPT (p > 0.05)
  • This indicates the postural exercise program did not confer additional benefits over duloxetine alone for these outcomes
  • Anxiety and depression were among the psychological outcomes assessed

The study enrolled 51 fibromyalgia patients randomized to an exercise group or control group, both receiving duloxetine therapy.

  • Patients were diagnosed with FMS according to the 2016 American College of Rheumatology criteria
  • Exercise group (EG): n = 26; Control group (CG): n = 25
  • The EG performed a home-based postural exercise program three times per week for four weeks in addition to duloxetine
  • Outcomes included pain intensity, pressure pain threshold (PPT), sleep quality, anxiety and depression, quality of life, and trunk range of motion (ROM)

The authors cautioned that findings should be interpreted carefully due to the short intervention duration and absence of follow-up assessment.

  • The intervention lasted only four weeks
  • No follow-up assessment was conducted after the intervention period
  • The authors characterized the benefits as 'short-term additional benefits'
  • These limitations restrict conclusions about the durability of the observed effects

What This Means

This research suggests that people with fibromyalgia who take the medication duloxetine may get extra benefits from also doing a structured postural exercise program at home. In this study, 51 fibromyalgia patients were divided into two groups: one group took duloxetine only, and the other group took duloxetine and also completed a series of postural exercises three times per week for four weeks. Both groups improved over time in pain, mood, sleep, and quality of life — likely because of the medication — but the exercise group showed meaningfully greater improvements specifically in sleep quality, physical quality of life, and the ability to bend and move the trunk/spine. The differences between groups were statistically significant and, in the case of spinal mobility, showed very large effect sizes. However, the exercise program did not provide extra benefit over medication alone for pain levels, anxiety, depression, mental well-being, or pain sensitivity at specific pressure points. This suggests that postural exercise may target certain aspects of fibromyalgia — particularly physical functioning and sleep — more effectively than others when combined with drug treatment. This research suggests that a relatively simple, home-based exercise routine could be a worthwhile addition to standard medication treatment for fibromyalgia, particularly for improving sleep and physical mobility. However, the study was short (only four weeks) and did not track patients after the program ended, so it is unclear whether these benefits last. Larger and longer studies with follow-up assessments are needed before firm conclusions can be drawn.

Check Your Own Numbers

Upload your bloodwork. We'll cross-reference your results against this study and 4,700 others.

Upload Your Labs

Have a question about this study?

Citation

Demir C, &#xd6;z&#xe7;elep &, Okumu&#x15f; E, Canl&#x131; M, Alkan H. (2026). Home-based postural exercise as an adjunct to duloxetine improves sleep quality, physical quality of life, and trunk mobility in fibromyalgia: a randomized controlled trial.. Rheumatology international. https://doi.org/10.1007/s00296-026-06137-w